Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals
World Rank (Aug-2026)
3203
Market Cap (Aug-2026)
5.988 Billion USD
World Rank (Jan-05-2024)
7,059
Market Cap (Jan-05-2024)
1.405 Billion USD
World Rank (Jul-30-2023)
7,387
Market Cap (Jul-30-2023)
1.325 Billion USD
World Rank (Jan-07-2022)
10,948
Market Cap (Jan-07-2022)
0.755 Billion USD
World Rank (Jan-01-2021)
7,213
Market Cap (Jan-01-2021)
1.203 Billion USD
Headquarters Country
Nasdaq / NYSE Code
KNSA
World Region
World Subregion
Annual Revenue in USD
678 Million USD
Annual Net Income in USD
59 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
764 Million USD
Total Liabilities in USD
196 Million USD
Total Equity in USD
568 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Company Website
Yahoo
Ads